- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Anna Hale appointed Chief Marketing Officer at Karo Pharma
Anna Hale joins Karo Pharma from GSK Healthcare, where she previously served as VP & Global Brand Lead, Gum Health & Family Oral Health.
Karo Pharma has appointed Anna Hale as the Chief Marketing Officer (CMO) of Karo.
“We are pleased that we have been able to attract Anna Hale to join the Karo team. Anna has a consistent track record of delivering substantial business results across different categories and markets. She brings deep international experiences to Karo and has a versatile toolbox within the marketing arena. She will lead the development and execution of differentiated brand programs, designed to accelerate growth across Karo’s brand portfolio”, says Christoffer Lorenzen, CEO.
Anna Hale joins Karo after 15 years at GSK Consumer Healthcare (GSK). Most recently, she has led Parodontax to become the world’s fastest growing toothpaste, through winning creative communication, a strong pipeline of innovation and geographic expansion into new, emerging markets.
Anna Hale will join Karo during Q4, 2021 and will be a part of the Corporate Management Team, reporting to Christoffer Lorenzen, CEO.
Beyond the Scrubs: Understanding Healthcare Providers as People for Increased Engagement
March 28th 2024The benefits of adopting a humanized approach to healthcare provider marketing extend across the healthcare spectrum, enhancing engagement rates, brand loyalty, and marketing ROI, while also driving better outcomes for patients.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
